Chemical Compounds

a technology of chemical compounds and derivatives, applied in the field of sulfonamide derivatives, can solve the problems of increasing the risk of gout with increased sua levels

Inactive Publication Date: 2015-09-17
PFIZER LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The new sulphonamide URAT-1 inhibitors demonstrate enhanced absorption, metabolic stability, and favorable pharmacokinetic properties, potentially offering better treatment options for gout with reduced side effects and improved patient tolerance.

Problems solved by technology

These crystals (known as tophi) trigger a local immune-mediated inflammatory reaction, leading to gout.
The risk of gout increases with increased sUA levels.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chemical Compounds
  • Chemical Compounds
  • Chemical Compounds

Examples

Experimental program
Comparison scheme
Effect test

example 1

4-(3-chloro-4-cyanophenoxy)-3-cyano-N-(5-fluoropyridin-2-yl)benzenesulfonamide

[0249]

3-Cyano-4-fluoro-N-(5-fluoropyridin-2-yl)benzenesulfonamide (Preparation 2, 10.5 g, 35.6 mmol) was added to a solution of 2-chloro-4-hydroxybenzonitrile (8.19 g, 53.3 mmol) and potassium carbonate (14.74 g, 106.7 mmol) in dimethylsulfoxide (100 mL) at room temperature. The resulting mixture was stirred at 80° C. for 44 hours. On cooling, the reaction mixture was poured into saturated aqueous sodium hydrogen carbonate solution (200 mL) and ethyl acetate (1000 mL) was added. The aqueous layer was separated and the organic layer was washed with saturated aqueous sodium hydrogen carbonate solution (3×200 mL), water (2×200 mL) and brine (2×200 mL). The organic layer was dried over sodium sulphate, filtered and concentrated in vacuo. The residue was purified by reverse phase column chromatography eluting with acetonitrile (containing 0.1% HCO2H): water (containing 0.1% HCO2H) from 0 to 100% to afford the t...

example 99

4-(4-cyano-3-fluorophenoxy)-2-fluoro-N-(5-fluoropyridin-2-yl)benzenesulfonamide

[0278]

[0279]To a solution of 5-bromo-4-(4-cyano-3-fluorophenoxy)-N-(2,4-dimethoxybenzyl)-2-fluoro-N-(5-fluoropyridin-2-yl)benzenesulfonamide (Preparation 1, 220 mg, 0.35 mmol) in THF (8 mL), AcOH (10 mL) and water (2.5 mL) was added zinc dust (800 mg, 12.2 mmol). The reaction mixture was left to stir at room temperature for 70 hours. To the reaction mixture was added EtOAc (25 mL) and the mixture filtered through celite and washed with EtOAc (50 mL). The filtrate was retained and to this was added saturated aqueous NaHCO3 (80 mL). The organic layer was retained, dried over MgSO4, and the solvent removed in vacuo. The residue was purified using reverse phase column chromatography eluting with acetonitrile and water (acidic). The residue was dissolved in DCM and treated with TFA (0.3 mL) and stirred at room temperature for 1 hour. The reaction was concentrated in vacuo azeotroping with MeOH. The residue was...

example 100

4-(3-chloro-4-cyanophenoxy)-3-cyano-N-(pyridin-4-yl)benzenesulfonamide

[0281]

[0282]The title compound was prepared according to the method described for Example 101 using 4-aminopyridine.

[0283]MS m / z 411 [M+H]+

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to new sulfonamide URAT-1 inhibitor compounds of formula (I) or a pharmaceutically acceptable salt thereof:to compositions containing them, to processes for their preparation and to intermediates used in such processes, and to methods of treatment, wherein R1, R2, R3, R4, R5 and R6 are as defined in the description.

Description

[0001]This application is a Continuation Application under 35 U.S.C. §120 of U.S. patent application Ser. No. 14 / 254,988 filed on Apr. 17, 2014 which claims the benefit of U.S. Provisional Patent Application No. 61 / 917,532 filed on Dec. 18, 2013 and U.S. Provisional Patent Application No. 61 / 813,809 filed on Apr. 19, 2013, the disclosures of which are hereby incorporated by reference in its entirety.FIELD OF THE INVENTION[0002]The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes.[0003]Uric acid is the final product of purine metabolism in humans. In humans, unlike many other animals, uric acid is not further broken down, but is predominantly (70%) excreted into the urine with the remaining 30% excreted in faeces. Hyperuricemia is defined as an excessive production or decreased excretion of uric acid and can occur as an overproduction or under excreti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(United States)
IPC IPC(8): C07D401/14A61K31/44A61K31/444A61K31/50C07D239/42A61K31/505C07D213/76C07D237/20
CPCC07D401/14C07D213/76A61K31/44A61K31/444A61K31/50C07D239/42A61K31/505C07D237/20A61P19/00A61P19/06C07D213/75C07D241/22C07D401/12
InventorSTORER, ROBERT IANSWAIN, NIGEL ALANOWEN, ROBERT MCKENZIE
OwnerPFIZER LTD